{
    "organizations": [],
    "uuid": "86a25ace911fc0456c5e716acb22c3526a6cae5e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-wuhan-hiteck-biological-pharma-pas/brief-wuhan-hiteck-biological-pharma-passes-review-of-high-tech-enterprise-recognition-idUSL4N1QH3KE",
    "ord_in_thread": 0,
    "title": "BRIEF-Wuhan Hiteck Biological Pharma passes review of high-tech enterprise recognition",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27(Reuters) - Wuhan Hiteck Biological Pharma Co Ltd\n* Says it passes the review of high-tech enterprise recognition and could enjoy a tax preference of 15 percent for three years\nSource text in Chinese: goo.gl/XPFoTm\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-27T16:23:00.000+02:00",
    "crawled": "2018-02-28T13:07:42.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "wuhan",
        "hiteck",
        "biological",
        "pharma",
        "co",
        "ltd",
        "say",
        "pass",
        "review",
        "enterprise",
        "recognition",
        "could",
        "enjoy",
        "tax",
        "preference",
        "percent",
        "three",
        "year",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}